Frost & Sullivan awards Mes Medical the 'China Digital Marketing Leadership Award'

Frost & Sullivan awards Mes Medical the 'China Digital Marketing Leadership Award'

2025/03/06

The 2nd New Investment Expo 2023 and the 17th Frost & Sullivan Global Growth, Innovation and Leadership Summit were held again at the 'World Salon' in Shanghai from September 27th to 28th, 2023. On September 28th, the 2023 Frost & Sullivan Global Awards for Growth, Innovation and Leadership, Asia-Pacific and China were grandly announced at the Frost & Sullivan Life Sciences New Investment Summit Forum.

 

Based on recent research and analysis of China's digital healthcare marketing and physician platform markets, as well as studies and evaluations of related companies in the industry, the globally renowned growth consulting firm Frost & Sullivan (Frost & Sullivan, abbreviated as Frost & Sullivan) awarded Shanghai Meis Medical Technology Co., Ltd. (hereinafter referred to as 'Meis Medical') the 'China Digital Marketing Leadership Award', which was presented by Dr. Wang Xin, a global partner and Chairman of Greater China at Frost & Sullivan, to Mr. Fan Jie, Co-CEO of Shanghai Meis Medical Technology Co., Ltd.

Frost & Sullivan awarded Meis Medical

the 'China Digital Marketing Leadership Award'

Dr. Wang Xin presented the award to Mr. Fan Jie, Co-CEO of Meis Medical

 

One of the largest online professional physician platform operators in China

Meis Medical was established in 2012 and is headquartered in Shanghai, China. As one of the largest online professional physician platform operators in China, Meis Medical uses big data and artificial intelligence technologies to connect doctors, patients, and pharmaceutical and medical device enterprises, empowering the healthcare ecosystem and improving healthcare quality.

 

Its services include physician platform solutions, real-world research solutions, precision omnichannel marketing solutions, APO innovative digital marketing solutions, and hospital digital research platform solutions, covering pharmaceutical marketing consulting, medical affairs empowerment, multi-channel academic dissemination, and other specialty services. It provides pharmaceutical and medical device enterprises with one-stop digital solutions for medicine, market access, and dissemination. Meis Medical's medical expertise and research support capabilities are highly recognized in the industry, and it has been empowered by cutting-edge technologies such as big data and artificial intelligence, enabling it to quickly perceive and capture industry trends in R&D and collaboratively promote the efficient development of various business segments.

 

Professional content output for physician platforms, safeguarding the development of physicians at all stages of their careers

The Meis Doctor Platform provides professional content push for physicians, medical institutions, as well as healthcare professionals and life science professionals. Meis Medical's leading medical academic knowledge and research support capabilities have formed a unique influence barrier for the physician group in the industry. As of June 30th, 2023, the platform has approximately 3 million registered physician users, with an average monthly active user of about 2.8 million in 2023. Thanks to the professionalism of its content output and precise push targeting user research areas, users can obtain the latest developments in research fields from mobile and computer terminals in a timely manner, cultivating users' habit of using the platform. Registered physician users with associate chief physician or above titles on the platform account for about 72% of the latest statistics of associate chief physicians or above titles from the National Health Commission, achieving wide coverage for senior Chinese doctors. Senior doctors have a high influence in the healthcare ecosystem and can promote the approval of innovative pharmaceuticals and medical devices, conduct clinical trials to expand indications, explore optimized treatment methods for diseases, and use their influence for academic promotion.

 

Precision omnichannel marketing solutions, addressing industry pain points based on big data and professionalism

Meis Medical's precision omnichannel marketing solutions can provide full-channel multi-modal precision marketing plans for all stages of the lifecycle of innovative drugs or medical devices. Traditional marketing has pain points such as high costs and limited reach, insufficient marketing content production capabilities, and low efficiency in medical decision-making. In contrast, digital methods can bring higher convenience to marketing and more accurate target group information delivery. Relying on the efficient driving ability of 'medical academia + digitalization' of the excellent doctor platform and strong professional content output capabilities, Meis Medical can fully explore the academic highlights of pharmaceutical products, analyze clinical application differences between different products, accurately match patients, enhance rationality in medication use, and fully reflect the clinical value of pharmaceutical and medical device products.

 

Real-world clinical research (RWS) solutions, helping with the post-marketing clinical application promotion of innovative drugs and medical devices

Currently, there are mainly three types of RWS solutions, including RWS based on physician platforms, RWS based on CROs, and RWS based on big data. Compared with other categories, RWS based on physician platforms has the advantages of more flexible service plans and lower costs. Meis Medical's strong medical academic support team and professional project operation team can provide one-stop services for sponsors, including research strategy and plan design, full-process project operation management, consultation and statistical analysis by internal and external statistical experts, publication strategy and support for research results. In addition, RWS research results can reflect the application of pharmaceutical and medical devices in the real-world environment, assist in safety and effectiveness evaluation, expand the indication scope of pharmaceutical and medical device products and accelerate the commercialization process of products. Combined with Meis Medical's digital marketing capabilities, it can further accelerate the promotion of pharmaceutical and medical device products among the indicated population.

 

APO innovative digital marketing solutions, empowering innovative drugs to grow rapidly

In response to industry pain points such as high commercialization costs and long cycles for innovative drugs and medical devices, Meis Medical's APO innovative digital marketing solutions provide three innovative service models: iDocEco Specialist Doctor Diagnosis and Treatment Collaboration Platform - precisely linking specialists in different disease areas across the country, efficiently promoting innovative drugs, and accelerating the expansion and penetration of innovative drugs; iPatFlow Patient Full Journey Management Service - providing convenient diagnostic tools, patient referral support, and innovative drug consultation services for doctors on the iDocEco platform. It helps doctors quickly screen and diagnose patients, enabling patients to obtain innovative drug treatment as early as possible; iMarkAcce Academic Marketing Accelerator - providing academic research topic services for experts on the iDocEco platform to verify the effectiveness and safety of innovative drugs, accelerating the understanding and familiarity of the unique clinical efficacy of innovative drugs by experts, and promoting standardized treatment.

 

Hospital digital research platform solutions, efficiently enhancing hospital clinical research capabilities and output

Meis Medical has created a leading hospital clinical research empowerment product - the Hospital Digital Research Platform Solution, through its excellent medical academic capabilities, advanced medical big data technology, and rich clinical research service experience. The business covers the construction of the hospital's scientific research big data center, construction of specialized disease databases, real-world research, scientific research talent cultivation, refined scientific research management, clinical research services, and scientific research achievement transformation, providing one-stop solutions for hospitals to enhance their scientific research capabilities and promote achievement output.

 

About the 2023 Frost & Sullivan Life Sciences New Investment Summit Forum

The 2023 Frost & Sullivan Life Sciences New Investment Summit Forum was held on September 27th - 28th with the theme 'New Directions for the Future & Forging Ahead'. It gathered more than 30 industry leaders, life science enterprises, investment institutions, and professional service institutions, focusing on new investment and financing opportunities in life sciences, and jointly discussing the capital and industrial forces for enterprises to navigate through cycles.

About the Frost & Sullivan China Leadership Award

The Frost & Sullivan China Leadership Award is an acknowledgment of an enterprise's outstanding performance and achievements in professional medical content output, market potential, customer service, brand, etc. The Frost & Sullivan team nominated a group of competitive outstanding enterprises to the independent judging panel through methods such as in-depth interviews, industry analysis, and secondary research. The independent judging panel composed of third-party investment and financing experts, financial experts, bankers, and well-known listed entrepreneurs conducted strict evaluations on the enterprises nominated by the Frost & Sullivan team and decided to award the 'China Digital Marketing Leadership Award' to Meis Medical.


联系我们
联系我们
电话

业务咨询热线

(021)54075836

微信
二维码

扫码关注官方微信公众号

返回顶部
返回顶部

联系我们

×
请选择职位类别
请选择
×